Safety and Efficacy of Pembrolizumab (MK-3475) Plus Binimetinib Alone or Pembrolizumab Plus Chemotherapy With or Without Binimetinib in Metastatic Colorectal Cancer (mCRC) Participants (MK-3475-651/KEYNOTE-651)
Clinical trial NCT03374254 · COMPLETED
Trial details
- NCT number
- NCT03374254
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-02-16
- Primary completion
- 2021-09-08
- Enrollment
- 116
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.